The NICHD conducts and supports a variety of clinical research projects related to pregnancy. Select a link below to learn more about these projects.
Featured NICHD Clinical Trials on Pregnancy
- The National Standard for Normal Fetal Growth
The goal of this study is to establish a standard for normal fetal growth and size for gestational age, create an individualized standard for fetal growth potential, and improve the accuracy of fetal weight estimation.
- The NICHD Fetal Growth Study: Twin Gestations
Researchers are examining how twins grow and develop inside the womb, with the goal of reducing pregnancy and newborn health problems, including preterm delivery and fetal growth disorders. This will complement the NICHD study on The National Standard for Normal Fetal Growth.
- Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b)
This study focuses on the 40% of pregnant American women who have never given birth. Very little research has been done on this group. The goal of this study is to find ways to identify women who might develop a problem during their pregnancy. The study focuses on high blood pressure, preterm delivery, and low-birth-weight infants.
- Pharmacokinetic Study of Anti-HIV Drugs During Pregnancy
This study hopes to determine what doses of anti-HIV medications are appropriate for pregnant women. This may control a woman's viral load and reduce the chance for transmission to the infant.
- Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
This study will investigate whether antenatal corticosteroids given to pregnant women at least 12 to 24 hours before they deliver at 34 to 36 weeks of gestation will decrease infants' need for oxygen support. Researchers will compare the use of steroids to a placebo. The study will also evaluate whether steroids improve the chances that the baby will not get sick from other causes.
NICHD Clinical Trials
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on pregnancy is available by consulting the link below or by calling 1-800-411-1222.